BioCryst Adds $350 Million in New Financing with Royalty Pharma and OMERS Capital Markets
22 nov. 2021 07h00 HE
|
BioCryst Pharmaceuticals, Inc.
—Provides funding for BCX9930/oral Factor D program across multiple indications— —Agreements supported by strength of ORLADEYO® (berotralstat) launch and confidence in future opportunity— NEW YORK,...
Mocana TrustCenter Delivers On-Device Protection for OT, IoT and IIoT RTOS and Enterprise Platforms
21 juil. 2021 10h52 HE
|
Mocana
SAN JOSE, Calif., July 21, 2021 (GLOBE NEWSWIRE) -- Mocana has released the latest version of its TrustCenter cybersecurity protection platform for embedded real-time operating systems (RTOS) and...
Proactive news headlines including VR Resources, Dalrada Corp, Cloud DX and Kenorland Minerals
14 juil. 2021 14h19 HE
|
Proactive Investors
New York , July 14, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies TNR...
LexaGene Retains Wolf Greenfield Intellectual Property Law Firm
14 juil. 2021 07h45 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., July 14, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a molecular diagnostics company that develops a fully automated rapid pathogen...
GT Gold Reports Results From Quash Pass Drilling
16 févr. 2021 07h30 HE
|
GT Gold Corp
VANCOUVER, British Columbia, Feb. 16, 2021 (GLOBE NEWSWIRE) -- GT Gold Corp. (TSX-V:GTT; OTCQX:GTGDF) (the “Company” or “GT Gold”) today announces the results of a drilling program at Quash Pass, on...
Kymera Therapeutics Strengthens Leadership with Key Appointments and Promotions
03 févr. 2021 07h00 HE
|
Kymera Therapeutics, Inc.
WATERTOWN, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule...
Royalty Pharma Acquires Royalty Interest in ORLADEYO and BCX9930 From BioCryst Pharmaceuticals
07 déc. 2020 08h45 HE
|
RP Management, LLC
NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma (Nasdaq: RPRX), BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) and Athyrium Capital Management, LP today...
BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management
07 déc. 2020 08h40 HE
|
BioCryst Pharmaceuticals, Inc.
NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX), Royalty Pharma plc (Nasdaq: RPRX) and Athyrium Capital Management, LP...
Precision BioSciences Announces U.S. Patent Trial and Appeal Board Upholds Allogeneic CAR T Patents
15 oct. 2020 07h00 HE
|
Precision Biosciences
DURHAM, N.C., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies...
High Real Estate Group Welcomes Armstrong Flooring Inc. Headquarters to Greenfield
29 juin 2020 14h00 HE
|
High Companies
LANCASTER, Pa., June 29, 2020 (GLOBE NEWSWIRE) -- Armstrong Flooring, Inc. (NYSE: AFI) will relocate its corporate headquarters to Greenfield in 2021. The 160-year-old global leader in the design...